MIDATECH PHARMA
MIDATECH PHARMA
Investors
Investors
Shareholder Information

Shareholder Meeting Notices

Date Title Document Webcast
12/02/2020 Shareholder Circular and Notice of General Meeting to be held on 2 March 2020
19/06/2019 Notice of 2019 AGM
05/02/2019 Shareholder Circular, Open Offer & Notice of General Meeting Panel Waiver
28/09/2018 Shareholder Circular and Notice of General Meeting to be held on 15 October 2018
13/08/2018 Notice of 2018 AGM
28/09/2017 Notice of General Meeting to be held on 16 October 2017
11/04/2017 Notice of Annual General Meeting 2017
12/10/2016 Notice of General Meeting to be held on 28 October 2016
11/05/2016 Notice of 2016 AGM
21/05/2015 Notice of 2015 AGM
Share Detail
Number of shares 23,494,981
Country of listing UK / US
Status AIM Listed / NASDAQ Listed
Index FTSE AIM All Share / NASDAQ
FTSE Sector Pharmaceutical & Biotechnology
FTSE sub-sector Biotechnology
Ticker MTPH / MTP
CUSIP GB00BKT14T00

The percentage of 0.1p Ordinary shares not being held in public hands is 74%

Shares held in treasury: Nil.

There are no restrictions on the transfer of Ordinary shares in the Company.

Information correct as at 4 March 2020.

Major Shareholders

Midatech Pharma has been notified or is aware of the following holdings of more than 3% or more of the issued share capital of the Company.

Name Number of shares %
CMS Medical Venture Investment (HK) Limited* 5,194,805 22.1
A&B (HK) Company Limited* 5,194,805 22.1
Link Fund Solutions Ltd 3,891,284 16.6
Armistice Capital LLC 2,296,778 9.8

* CMS Medical Venture Investment (HK) Limited and A&B (HK) Company Limited are considered a Concert Party

Information correct as at 4 March 2020.

ADR Information
Ticker Structure Exchange Ratio DR ISIN CUSIP
MTP Level III ADR NASDAQ 1 ADR : 5 Ordinary Shares US59564R3021 59564R302